Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Trends & Strategies in the $2.9 Billion Biological Computing Market, 2026-2035 - Featuring Profiles of Microsoft, IBM, and Thermo Fisher Scientific

globenewswire.com
MSFT Microsoft is mentioned as a company featured in a report on the biological computing market, indicating its potential involvement or interest in this growing sector. The article does not provide specific details on Microsoft's performance or strategy within this market. IBM IBM is listed as a company featured in a report on the biological computing market. The article does not offer specific insights into IBM's current activities or performance in this sector, suggesting a general inclusion in market analysis. TMO Thermo Fisher Scientific is named as a company profiled in the biological computing market report. The article does not provide specific details about their performance or strategic positioning within this emerging field.

Trends & Strategies in the $2.9 Billion Biological Computing Market, 2026-2035 - Featuring Profiles of Microsoft, IBM, and Thermo Fisher Scientific Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The "Biological Computing Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The global biological computing market is experiencing exponential growth, supported by advances in DNA sequencing, synthetic biology, genomics research and bioinformatics. The market is projected to increase from $2.21 billion in 2025 to $2.90 billion in 2026, representing a compound annual growth rate (CAGR) of 31.2%.

Historical biological computing market growth has been driven by expanding genomics research funding, improvements in DNA sequencing technologies and the development of sophisticated synthetic biology techniques. Demand for alternatives to conventional high-performance computing systems and the continued expansion of bioinformatics research ecosystems have also contributed to the market's rapid development.

The biological computing market is forecast to reach $8.64 billion by 2030, expanding at a CAGR of 31.4% from 2026. Growth during the forecast period is expected to be fueled by demand for ultra-energy-efficient computing systems, greater adoption of personalized medicine, breakthroughs in DNA data storage and the expansion of hybrid biological-digital computing models. Increasing investment in biotechnology computing startups is also expected to support innovation and commercialization across the sector.

Key biological computing market trends include the scaling of DNA-based computational architectures, the emergence of synthetic biology-driven computing systems and the development of bio-integrated hybrid computing platforms. Molecular data storage and retrieval systems are gaining momentum, while laboratory automation is improving the speed, consistency and scalability of biocomputing workflows.

The increasing adoption of synthetic biology technologies is anticipated to be a significant market growth driver. Advances in genetic engineering and biotechnology are enabling researchers to design and modify living organisms for medical, pharmaceutical and industrial applications. Biological computing supports this progress by allowing engineered cells and biological systems to process information, execute logical operations and provide precise control over biological functions.

Growth in global genomic data highlights the expanding need for advanced biological computing capabilities. GenBank, the public genetic sequence repository maintained by the US-based National Center for Biotechnology Information, contained approximately 25 trillion base pairs and 3.7 billion sequences in 2024. By 2025, the database had expanded to around 34 trillion base pairs and 4.7 billion sequences, demonstrating substantial year-over-year growth in sequencing output and genomic data accumulation.

Innovation in cloud-enabled biocomputing research platforms is further advancing the market. In May 2024, Switzerland-based biotechnology research company FinalSpark SA launched Neuroplatform, a remote research platform that enables scientists to conduct biocomputing experiments using human brain organoids. The platform provides cloud-based access to living neuron systems, supports real-time electrical stimulation and records electrophysiological responses through multi-electrode arrays.

Neuroplatform also enables remote experiment control, real-time monitoring and continuous data acquisition from living neuronal networks. Its ability to maintain biological systems for extended periods under controlled laboratory conditions supports ongoing experimentation in organoid-based neural computation. These capabilities are helping researchers accelerate brain-inspired computing studies and explore energy-efficient, adaptive computing technologies.

Strategic collaborations are also supporting the development of hybrid intelligence systems. In November 2023, Canada-based artificial intelligence company VERSES Technologies Inc. formed a beta partnership with Australia-based neurotechnology company Cortical Labs Pty Ltd. The collaboration focuses on combining artificial intelligence frameworks with laboratory-cultivated neuronal networks to evaluate new biological computing methods. The initiative is expected to advance experimentation involving hybrid systems that integrate silicon-based computation with living biological neurons.

North America was the largest region in the biological computing market in 2025, while Asia-Pacific is expected to record the fastest growth during the forecast period. The biological computing market report covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. Countries analyzed include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy and Spain.

Markets Covered:

1) By Component: Hardware And Devices; Consumables; Software; Services

2) By Technology: Deoxyribonucleic Acid (DNA)-Based Computing; Cell-Based Computing; Protein-Based Computing; Molecular Or Biochemical Computing

3) By Deployment: Biocomputing-As-A-Service (BaaS); On-Premise Wet Kits

4) By Application: Data Storage And Archiving; Drug Discovery And Bioinformatics; Biosensing And Diagnostics; Complex Optimization

5) By End-User: Pharmaceuticals And Biotechnology; Academic And Research Institutes; Information Technology And Data Storage Providers; Healthcare And Diagnostics; Environmental And Industrial Applications

Subsegments:

1) By Hardware And Devices: Biological Computing Hardware Platforms; Biosensors; Microfluidic Chips; Deoxyribonucleic Acid Sequencers; Laboratory Automation Systems; Biological Processing Units

2) By Consumables: Reagents; Enzymes; Nucleotides; Biological Samples; Assay Kits; Cell Culture Media

3) By Software: Bioinformatics Software; Computational Biology Platforms; Molecular Modeling Software; Biological Data Analysis Software; Workflow Management Software; Simulation And Modeling Software

4) By Services: Contract Research Services; Deoxyribonucleic Acid Sequencing Services; Biological Data Analysis Services; Cloud Based Computing Services; Biotechnology Consulting Services; Laboratory Outsourcing Services

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

The companies featured in this Biological Computing market report include:

For more information about this report visit https://www.researchandmarkets.com/r/umk0xw

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.